Key result
Plasma lipidomic analysis identified 18 lipid species significantly associated with non-calcified coronary plaque burden in asymptomatic patients at intermediate CAD risk.
Why the study?
Does plasma lipidomic analysis predict non-calcified coronary artery plaque burden in asymptomatic patients at intermediate risk of CAD?
Population
100 asymptomatic patients at intermediate CAD risk according to the Framingham risk score
Design
Cross-sectional
Authors
Loading...
May support risk re-stratification in intermediate CAD; hypothesis-generating and requires prospective validation before clinical use.
Observational (n=100)
Does plasma lipidomic analysis predict non-calcified coronary artery plaque burden in asymptomatic patients at intermediate risk of CAD?
Plasma lipidomic analysis can predict the burden of non-calcified coronary plaque in asymptomatic subjects at intermediate risk of CAD, potentially aiding in risk re-stratification.
Ellims et al. (2014) conducted an observational in Asymptomatic intermediate risk of coronary artery disease (n=100). Plasma lipidomic analysis was evaluated on Burden of total, calcified, and non-calcified coronary artery plaque. Plasma lipidomic analysis identified 18 lipid species significantly associated with non-calcified coronary plaque burden in asymptomatic patients at intermediate CAD risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: